Frederic Zenhausern

Dr. Zenhausern ("Dr. Z") has several academic affiliations. At present, he is co-Chair and Endowed Chair Professor of Basic Medical Sciences, Professor of Clinical Translational Sciences, Professor of Radiation Oncology at the College of Medicine, Phoenix, and Director of the Center for Applied Nanobioscience and Medicine (ANBM) at the University of Arizona. He is also member of the Therapeutic Development Program at the University of Arizona’s Cancer Center, member of BIO5 and Professor at the Department of Biomedical Engineering, College of Engineering.

Dr. Zenhausern is a clinical research investigator at the Honor Health Research Institute. Dr. Zenhausern is also professor at the Translational Genomics Research Institute (TGen) and adjunct professor at the University of Geneva’s School of Pharmaceutical Sciences. He is Fellow of the U.S. National Academy of Inventors (NAI) and a Fellow of the American Institute of Medical and Biological Engineering (AIMBE).

He is co-founder of 4 successful startup companies and authored more than 80 peer-reviewed publications and proceedings with more than 30 U.S. Patents. He spent over a decade in industry at IBM T.J. Watson Research Center and Motorola Labs, where he pioneered ultra-high-resolution imaging spectroscopies and genomic platforms.

Dr. Zenhausern received his B.S. in biochemistry from the University of Geneva, his M.B.A. in finance from Rutgers University and his Doctorate Es Science in Applied Physics / Condensed Matter at the University of Geneva.

Zenhausern team pioneered organ-on-chip technology, rapid DNA forensics, molecular diagnostics for early disease detection but also portable fuel cell technologies for wearable electronics.

More recently, Dr. Zenhausern technology was selected to be the first molecular diagnostics to be performed in spaceflight by the civilian crew astronauts from the Space X Inspiration 4 mission.

July 2022